MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with P

Proguanil + Atovaquone

Proguanil 25mg / Atovaquone 62.5mg tablets

No stability information

Stability notes for Proguanil 25mg / Atovaquone 62.5mg tablets

There are no stability notes for this medicine.

Suppliers

Malarone Paediatric 62.5mg/25mg tablets (GlaxoSmithKline UK Ltd)
Proguanil 25mg / Atovaquone 62.5mg tablets (Alliance Healthcare (Distribution) Ltd)
Proguanil 25mg / Atovaquone 62.5mg tablets (Amarox Ltd)

Proguanil 100mg / Atovaquone 250mg tablets

Compatible

Stability notes for Proguanil 100mg / Atovaquone 250mg tablets

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Malarone 250mg/100mg tablets (GlaxoSmithKline UK Ltd).

Suppliers (11) of Proguanil 100mg / Atovaquone 250mg tablets
Malarone 250mg/100mg tablets (CST Pharma Ltd)
Malarone 250mg/100mg tablets (GlaxoSmithKline UK Ltd)
Malarone 250mg/100mg tablets (Necessity Supplies Ltd)
Malarone 250mg/100mg tablets (Sigma Pharmaceuticals Plc)
Maloff Protect 250mg/100mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Proguanil 100mg / Atovaquone 250mg tablets (A A H Pharmaceuticals Ltd)
Proguanil 100mg / Atovaquone 250mg tablets (Accord-UK Ltd)
Proguanil 100mg / Atovaquone 250mg tablets (Alliance Healthcare (Distribution) Ltd)
Proguanil 100mg / Atovaquone 250mg tablets (Amarox Ltd)
Proguanil 100mg / Atovaquone 250mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Proguanil 100mg / Atovaquone 250mg tablets (Viatris UK Healthcare Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.